We've found
161,353
archived clinical trials in
Cancer
We've found
161,353
archived clinical trials in
Cancer
First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
Click here to add this to my saved trials

First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
Click here to add this to my saved trials

First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
Click here to add this to my saved trials

First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
Click here to add this to my saved trials

First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
Click here to add this to my saved trials

First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
Click here to add this to my saved trials

First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
Click here to add this to my saved trials

First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
Click here to add this to my saved trials

First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
Click here to add this to my saved trials

First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
Click here to add this to my saved trials

First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
Click here to add this to my saved trials

First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
Click here to add this to my saved trials

First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
Click here to add this to my saved trials

First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
Click here to add this to my saved trials

First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
Click here to add this to my saved trials

First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
Click here to add this to my saved trials

First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
Click here to add this to my saved trials

First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
Click here to add this to my saved trials

First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
Click here to add this to my saved trials

First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
Click here to add this to my saved trials

First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
Click here to add this to my saved trials

First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
Click here to add this to my saved trials

First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
Click here to add this to my saved trials

First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
Click here to add this to my saved trials

First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
Click here to add this to my saved trials

First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
Click here to add this to my saved trials

First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
Click here to add this to my saved trials

First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
Click here to add this to my saved trials

First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
Click here to add this to my saved trials

First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
Click here to add this to my saved trials

First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
Click here to add this to my saved trials

First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
Click here to add this to my saved trials

First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
Click here to add this to my saved trials

First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
Click here to add this to my saved trials

First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
Click here to add this to my saved trials

First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
Click here to add this to my saved trials

First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
Click here to add this to my saved trials

First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
Click here to add this to my saved trials

First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
Click here to add this to my saved trials

First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
Click here to add this to my saved trials

First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
Click here to add this to my saved trials

First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
Click here to add this to my saved trials

First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
Click here to add this to my saved trials

First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
Click here to add this to my saved trials

First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
Click here to add this to my saved trials

First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
Updated: 4/13/2017
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 4/13/2017
Click here to add this to my saved trials

Effects of 'R' (Electro-kinetic Beverage) on Insomnia, Fatigue, and Depression in Breast Cancer Patients Having Adjuvant Chemo
Updated: 4/17/2017
A Pilot Study Evaluating the Effect of 'R' (Electro-Kinetically Altered Beverage) on Insomnia, Fatigue and Depression in Breast Cancer Patients Receiving Adjuvant Chemotherapy
Status: Enrolling
Updated: 4/17/2017
Effects of 'R' (Electro-kinetic Beverage) on Insomnia, Fatigue, and Depression in Breast Cancer Patients Having Adjuvant Chemo
Updated: 4/17/2017
A Pilot Study Evaluating the Effect of 'R' (Electro-Kinetically Altered Beverage) on Insomnia, Fatigue and Depression in Breast Cancer Patients Receiving Adjuvant Chemotherapy
Status: Enrolling
Updated: 4/17/2017
Click here to add this to my saved trials

Effects of 'R' (Electro-kinetic Beverage) on Insomnia, Fatigue, and Depression in Breast Cancer Patients Having Adjuvant Chemo
Updated: 4/17/2017
A Pilot Study Evaluating the Effect of 'R' (Electro-Kinetically Altered Beverage) on Insomnia, Fatigue and Depression in Breast Cancer Patients Receiving Adjuvant Chemotherapy
Status: Enrolling
Updated: 4/17/2017
Effects of 'R' (Electro-kinetic Beverage) on Insomnia, Fatigue, and Depression in Breast Cancer Patients Having Adjuvant Chemo
Updated: 4/17/2017
A Pilot Study Evaluating the Effect of 'R' (Electro-Kinetically Altered Beverage) on Insomnia, Fatigue and Depression in Breast Cancer Patients Receiving Adjuvant Chemotherapy
Status: Enrolling
Updated: 4/17/2017
Click here to add this to my saved trials

Effects of 'R' (Electro-kinetic Beverage) on Insomnia, Fatigue, and Depression in Breast Cancer Patients Having Adjuvant Chemo
Updated: 4/17/2017
A Pilot Study Evaluating the Effect of 'R' (Electro-Kinetically Altered Beverage) on Insomnia, Fatigue and Depression in Breast Cancer Patients Receiving Adjuvant Chemotherapy
Status: Enrolling
Updated: 4/17/2017
Effects of 'R' (Electro-kinetic Beverage) on Insomnia, Fatigue, and Depression in Breast Cancer Patients Having Adjuvant Chemo
Updated: 4/17/2017
A Pilot Study Evaluating the Effect of 'R' (Electro-Kinetically Altered Beverage) on Insomnia, Fatigue and Depression in Breast Cancer Patients Receiving Adjuvant Chemotherapy
Status: Enrolling
Updated: 4/17/2017
Click here to add this to my saved trials

Effects of 'R' (Electro-kinetic Beverage) on Insomnia, Fatigue, and Depression in Breast Cancer Patients Having Adjuvant Chemo
Updated: 4/17/2017
A Pilot Study Evaluating the Effect of 'R' (Electro-Kinetically Altered Beverage) on Insomnia, Fatigue and Depression in Breast Cancer Patients Receiving Adjuvant Chemotherapy
Status: Enrolling
Updated: 4/17/2017
Effects of 'R' (Electro-kinetic Beverage) on Insomnia, Fatigue, and Depression in Breast Cancer Patients Having Adjuvant Chemo
Updated: 4/17/2017
A Pilot Study Evaluating the Effect of 'R' (Electro-Kinetically Altered Beverage) on Insomnia, Fatigue and Depression in Breast Cancer Patients Receiving Adjuvant Chemotherapy
Status: Enrolling
Updated: 4/17/2017
Click here to add this to my saved trials
